tert-butyl (S)-3-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)pyrrolidine-1-carboxylate

Catalog No.: 
ACQHBE454
CAS No.: 
1421048-77-2
Molecular Formula: 
C18H24N2O5
Molecular Weight: 
348.40
tert-butyl (S)-3-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (S)-3-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl (S)-3-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)pyrrolidine-1-carboxylate
Molecular FormulaC18H24N2O5
Molecular Weight348.40
SMILESCC(C)(C)OC(=O)N1CC[C@H](NC(=O)C2=CC3=C(C=C2)OCCO3)C1
InChI KeyCBBNKJLVJCDMHW-ZDUSSCGKSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-[[(2,3-dihydro-1,4-benzodioxin-6-yl)carbonyl]amino]-, 1,1-dimethylethyl ester, (3S)-
CAS No.1421048-77-2

Synthetic Route by SureRoute

1. ACQHBE454 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAJIN238 route compound structure diagram
    ACAJIN2384442-54-0In Stock
  4. Then
  5. ACQHBE454 route product structure diagram
    ACQHBE4541421048-77-2
Inquiry

2. ACQHBE454 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLPHF072 route compound structure diagram
    ACLPHF07220197-75-5In Stock
  4. Then
  5. ACQHBE454 route product structure diagram
    ACQHBE4541421048-77-2
Inquiry

3. ACQHBE454 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQHBE454 route product structure diagram
    ACQHBE4541421048-77-2
Inquiry

Comments (0)